Skip to main content
SpringerLink
Log in

Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Numerous data support the hypothesis that dopamine (DA) plays a crucial role in reward-related processes and in incentive learning in animals and man. The possibility that various neuroleptics exhibiting a high affinity for the dopaminergic D2 (and D3) receptors could reinforce DA transmission was studied using the conditioned place preference paradigm (CPP) in rats. This was done by examining the ability of these compounds to potentiate the reinforcing properties of food in hungry rats subjected to a version of the CPP paradigm which consisted of repeated pairings of food with a single environmental cue, the floor texture of an open field. During the test session when food was no longer available in the open field, the increase in the time spent by drug-free rats on the food-paired texture was assumed to indicate the perceived rewarding value of the food. This time was significantly lengthened when the specific D2 (D3)-receptor antagonists sulpiride (4 mg/kg), amisulpride (0.5, 1 mg/kg) or pimozide (0.03, 0.06 mg/kg) were administered before the food conditioning sessions. Larger doses of these compounds as well as haloperidol, metoclopramide and the non-specific D1-D2 antagonist, chlorpromazine, regardless of the doses tested, did not exhibit this effect, but rather reduced the food-induced CPP, an action usually associated with neuroleptics. The positive effects of amisulpride was reversed by a D1 receptor antagonist, SCH 23390 (0.01 mg/kg). These results suggest that, as with amphetamine (0.5 mg/kg), some D2-specific neuroleptics enhance the incentive value of food in a narrow range of low doses, an effect proposed to reflect a “prohedonic” property. The potentiation of the release of DA unconditionally evoked by food, through a selective blockade of the release-modulating D2-autoreceptors, could constitute the neurobiological substratum of this effect. A concomitant blockade of either D2 or D1 postsynaptic receptors, however, appeared to be sufficient to counteract such activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Acquas E, Carboni E, Leone P, Di Chiara G (1989) SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology 99:151–155

    Google Scholar 

  • Ahlenius S (1992) Effects of the local application of 3-PPP and sulpiride enantiomers into the nucleus accumbens or into the ventral tegmental area on rat locomotor activity: evidence for the functional importance of somato-dendritic autoreceptors. Naunyn Schmiedebergs Arch Pharmacol 345:516–522

    Google Scholar 

  • Beninger RJ (1991) Receptor subtype-specific dopamine agonists and antagonists and conditioned behaviour. In: Willner P, Scheel Krüger J (eds) The mesolimbic dopamine system: from motivation to action, Wiley, Chichester, pp 273–299

    Google Scholar 

  • Beninger RJ, Freedman NL (1982) The use of two operants to examine the nature of pimozide-induced decreases in responding for brain stimulation. Physiol Psychol 10:409–412

    Google Scholar 

  • Brown F, Campbell W, Mitchell PJ, Randall K (1985) Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis. Br J Pharmacol 84:853–860

    Google Scholar 

  • Bull DR, Sheehan MJ (1991) Presynaptic regulation of electrically evoked dopamine overflow in the nucleus accumbens: a pharmacological study using fast cyclic voltametry in vivo. Naunyn Schmiedebergs Arch Pharmacol 343:260–265

    Google Scholar 

  • Cabib S, Castellano C, Cestari V, Filibeck U, Puglisi-Allegra S (1991) D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse. Psychopharmacology 105:335–339

    Google Scholar 

  • Cador M, Robbins TW, Everitt BJ (1989) Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. Neuroscience 30:77–86

    Google Scholar 

  • Carr GD, Phillips AG, Fibiger HC (1988) Independence of amphetamine reward from locomotor stimulation demonstrated by conditioned place preference. Psychopharmacology 94:221–226

    Google Scholar 

  • Carr GD, Fibiger HC, Phillips AG (1989) Conditioned place preference as a measure of drug reward. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Oxford University Press, Oxford, pp 264–319

    Google Scholar 

  • Carnoy P, Ravard S, Hervé D. Tassin JP, Soubrié P (1987) Apomorphine induced operant deficits: a neuroleptic-sensitive but drug and dose-dependent animal model of behavior. Psychiatrie & Psychobiologie II [4]:266–273

    Google Scholar 

  • Clark D, White FJ (1987) Review: D1 dopamine receptor-the search for a function: a critical evaluation of the D1-D2 dopamine receptor classification and its functional implications. Synapse 1:347–388

    Google Scholar 

  • Costall B, Lim SK, Naylor RJ (1981) Characterisation of the mechanism by which purported dopamine agonists reduce spontaneous locomotor activity of mice. Eur J Pharmacol 73:175–188

    Google Scholar 

  • Di Scala G, Sandner G (1989) Conditioned place aversion produced by FG 7142 is attenuated by haloperidol. Psychopharmacology 99:176–180

    Google Scholar 

  • Hernandez L, Hœbel BG (1988) Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci 42:1705–1712

    Google Scholar 

  • Hill RT (1970) Facilitation of conditioned reinforcement as a mechanism of psychomotor stimulation. In: Costa E, Garattini S (eds) Amphetamines and related compounds. Raven Press, New York, pp 781–795

    Google Scholar 

  • Hiroi N, White NM (1991) The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res 552:141–152

    Google Scholar 

  • Hoffman DC, Beninger RJ (1989) The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats. Pharmacol Biochem Behav 33:273–279

    Google Scholar 

  • Imperato A, Di Chiara G (1988) Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Eur J Pharmacol 156:385–393

    Google Scholar 

  • Jenner P, Marsden CD (1982) The mode of action of sulpiride as an atypical antidepressant agent. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: clinical practice. Raven Press, New York, pp 85–103

    Google Scholar 

  • Katz JL (1989) Drugs as reinforcers: pharmacological and behavioral factors. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Oxford University Press, Oxford, pp 164–213

    Google Scholar 

  • Koob GF, Goeders NE (1989) Neuroanatomical substrates of drug self administration. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Oxford University Press, Oxford, pp 214–263

    Google Scholar 

  • Kullingsjö H, Carlsson A, Svenson K (1991) Effects of repeated administration of the preferential dopamine autoreceptor antagonist, (+)-AJ76, on locomotor activity and brain DA metabolism in the rat. Eur J Pharmacol 205:241–246

    Google Scholar 

  • Lecrubier Y, Puech AJ, Aubin F, Boyer P, Deyrieux B (1988) Improvement by amisulpride of the negative symptoms in nonpsychotic subjects: a preliminary study. Psychiatrie & Psychobiologie 3:341–350

    Google Scholar 

  • Lynch MR (1991) Dissociation of autoreceptor activation and behavioural consequences of low dose apomorphine treatment. Prog Neuropsychopharmacol Biol Psychiatry 15:689–698

    Google Scholar 

  • Mackey WB, van der Kooy D (1985) Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning. Pharmacol Biochem Behav 22:101–105

    Google Scholar 

  • Maubrey MC, Jacquot C, Godinec J, Guez M, Idée JM, Margarit J (1989) Amisulpride: pharmacological profiles. In: Borenstein P, Boyer P, Braconnier P et al (eds) Amisulpride. Expansion Scientifique Française, Paris, pp 3–24

    Google Scholar 

  • Mindham RHS, Jerram TC, Cole HL, Oswald AG, Khan S (1991) A comparison of sulpiride, dothiepin, diazepam and placebo in the treatment of depressed out-patients. J Psychopharmacol 5:259–262

    Google Scholar 

  • Moghaddam B, Bunney BS (1990) Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem 54:1755–1760

    Google Scholar 

  • Petit M, Zann M, Colonna L (1984) Etude contrôlée de l'effet désinhibiteur de faibles doses de sulpiride dans les psychoses schizophréniques déficitaires. Encéphale X:25–28

    Google Scholar 

  • Phillips AG, Pfaus JG, Blaha CD (1991) Dopamine and motivated behavior: insights provided by in vivo analyses. In: Willner P, Scheel-Krüger J (eds) The mesolimbic dopamine system: from motivation to action. Wiley, Chichester, pp 199–224

    Google Scholar 

  • Puech AJ, Rioux P, Poncelet M, Brochet D, Chermat R, Simon P (1981) Pharmacological properties of new antipsychotic agents: use of animal models. Neuropharmacology 20:1279–1284

    Google Scholar 

  • Puglisi-Allegra S, Cabib S (1988) The dopamine D2 agonists induces catalepsy in the mouse. Pharmacol Biochem Behav 30:765–768

    Google Scholar 

  • Robbins TW (1978) The acquisition of responding with conditioned reinforcement: effects of pipradrol, methylphenidate,d-amphetamine, and nomifensine. Psychopharmacology 58:79–87

    Google Scholar 

  • Robertson A, McDonald C (1985) Opposite effects of sulpiride and metoclopramide on amphetamine-induced stereotypy. Eur J Pharmacol 109:81–89

    Google Scholar 

  • Sallers CF, Salama AI (1985) Dopamine receptor subtypes: in vivo biochemical evidence for functional interaction. Eur J Pharmacol 109:297–300

    Google Scholar 

  • Santiago M, Westerink BHC (1991) Characterisation and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. J Neurochem 57:738–747

    Google Scholar 

  • Sokoloff P, Martres MP, Redouane K, Schwartz JC, Protais P, Vasse M, Dubuc I, Costentin J, Hamdi P, Mann A, Wermuth CG (1987) Behavioral and neurochemical profiles of discriminant benzamine derivatives. Psychiatrie & Psychobiologie II [4]:253–264

    Google Scholar 

  • Sokoloff P, Giros B, Martres MP, Bouthenet M, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146–151

    Google Scholar 

  • Spyraki C, Fibiger HC, Phillips AG (1982) Attenuation by haloperidol of place preference conditioning using food reinforcement. Psychopharmacology 77:379–382

    Google Scholar 

  • Spyraki C, Fibiger HC, Phillips AG (1983) Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system Psychopharmacology 79:278–283

    Google Scholar 

  • Ståhle L (1992) Do autoreceptors mediate dopamine agonist-induced yawning and suppression of exploration? A critical review. Psychopharmacology 106:1–13

    Google Scholar 

  • Ståhle L, Ungerstedt U (1990) Yawning and suppression of exploration induced by dopamine agonists: no relation to extracellular striatal levels of dopamine. Pharmacol Biochem Behav 35:201–209

    Google Scholar 

  • Stellar JR, Rice MB (1989) Pharmacological basis of intracranial self-stimulation reward. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Oxford University Press, Oxford, pp 14–65

    Google Scholar 

  • Svenson K, Kling-Petersen T, Waters N, Ekman A, Carlsson A (1991) The preferential dopamine autoreceptor antagonist (+)-AJ76 increases motor activity in habituated rats and antagonizesd-amphetamine-induced hyperactivity. Posters Neurosci 1:75–79

    Google Scholar 

  • Talmaciu RK, Hoffman IS, Cubeddu LX (1986) Dopamine autoreceptors modulate dopamine release from the prefrontal cortex. J Neurochem 47:865–870

    Google Scholar 

  • Taylor JR, Robbins TW (1986) 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbensd-amphetamine. Psychopharmacology 90:390–397

    Google Scholar 

  • Triet D (1990) A comparison of benzodiazepine, serotonin, and dopamine agents in the taste-reactivity paradigm. Pharmacol Biochem Behav 37:451–456

    Google Scholar 

  • Vezina P, Stewart J (1987) Conditioned locomotion and place preference elicited by tactile cues paired exclusively with morphine in an openfield. Psychopharmacology 91:375–380

    Google Scholar 

  • Walters JR, Bergstrom DA, Carlson JH, Chase TN, Braun, AR (1987) D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science 236:719–722

    Google Scholar 

  • Westerink BHC, de Vries JB (1989) On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci Lett 99:197–202

    Google Scholar 

  • White NM, Carr GD (1985) The conditioned place preference is affected by two independent reinforcement processes. Pharmacol Biochem Behav 23:37–42

    Google Scholar 

  • Willner P, Phillips G, Muscat R (1991) Suppression of rewarded behaviour by neuroleptic drugs: can't or won't and why? In: Willner P, Scheel-Krüger J (eds) The mesolimbic dopamine system: from motivation to action. Wiley, Chichester, pp 251–271

    Google Scholar 

  • Wise RA (1982) Neuroleptics: the anhedonia hypothesis. Behav Brain Sci 5:39–87

    Google Scholar 

  • Wise RA, Bozarth MA (1981) Brain substrates for reinforcement and drug self administration. Progr Neuropsychopharmacol Biol Psychiatry 5:467–474

    Google Scholar 

  • Wolf ME, Roth RH (1987) Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors. Neuropharmacology 26:1053–1059

    Google Scholar 

Download references

Author information

Author notes

  1. Grazyna Biala

    Present address: Department of Pharmacodynamic, Staszica 4, 20-081, Lublin, Poland

Authors and Affiliations

  1. Département de Pharmacologie, Faculté de Médecine Pitié-Salpêtriére, INSERM U-302, 91, boulevard de l'Hôpital, 75634, Paris Cedex 13, France

    Alice Guyon, Françoise Assouly-Besse, Grazyna Biala & Alain J. Puech

  2. Département de Pharmacologie, Faculté de Médecine Pitié-Salpêtriére, INSERM U-288, 91, boulevard de l'Hôpital, 75634, Paris Cedex 13, France

    Marie-Hélène Thiébot

Authors
  1. Alice Guyon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Françoise Assouly-Besse
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Grazyna Biala
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alain J. Puech
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marie-Hélène Thiébot
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guyon, A., Assouly-Besse, F., Biala, G. et al. Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats. Psychopharmacology 110, 460–466 (1993). https://doi.org/10.1007/BF02244653

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244653

Key words

Search

Navigation